Differences in the Plasma Membrane Proteins of Chronic Alcoholic Rat Brain
- 期刊名称Molecular Membrane Biology
- 作者Babu, Phanithi Prakasa; Nagaraju, Nivarthi; Vemuri, Mohan C.
- 卷第9卷
- 期第3期
- 印刷ISSN0968-7688
- 电子ISSN1464-5203
- 文件大小835.42KB
- 发表时间1990-01
- DOI10.3109/09687689009025843
- 页码227-237
Disposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHe, H.; Tran, P.; Yin, H.; Smith, H.; Flood, D.; Kramp, R.; Filipeck, R.; Fischer, V.; Howard, D. · Drug Metabolism and Disposition · 2009
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic ratsZhang, Qian; Xiao, Xinhua; Zheng, Jia; Li, Ming; Yu, Miao; Ping, Fan; Wang, Tong; Wang, Xiaojing · Archives of Medical Science · 2019
Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHe, H.; Tran, P.; Yin, H.; Smith, H.; Batard, Y.; Wang, L.; Einolf, H.; Gu, H.; Mangold, J. B.; Fischer, V.; Howard, D. · Drug Metabolism and Disposition · 2009
An Update of Recent Trials with Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 DiabetesJohnson, J. T.; Golden, K. L.; Braceras, R. · Journal of Pharmacy Technology · 2009
Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in ratsMiyoshi, Toru; Nakamura, Kazufumi; Yoshida, Masashi; Miura, Daiji; Oe, Hiroki; Akagi, Satoshi; Sugiyama, Hiroki; Akazawa, Kaoru; Yonezawa, Tomoko; Wada, Jun; Ito, Hiroshi · Cardiovascular Diabetology · 2014
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes MellitusEvans, Marc; Kozlovski, Plamen; Paldánius, Päivi M.; Foley, James E.; Bhosekar, Vaishali; Serban, Carmen; Avogaro, Angelo · Diabetes Therapy · 2017
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, ameliorates the development of CaCl2-induced abdominal aortic aneurysm in mice via anti-inflammatory effectsNoda, Y.; Miyoshi, T.; Yonezawa, T.; Oe, H.; Toh, N.; Oono, Y.; Nakamura, K.; Morita, H.; Kusano, K.; Ito, H. · European Heart Journal · 2013
Pharmacokinetic evaluation of axitinibPatson, Brian; B Cohen, Roger; Olszanski, Anthony J. · Expert Opinion on Drug Metabolism & Toxicology · 2012
Advances in paediatric pharmacokineticsKnibbe, Catherijne AJ; Krekels, Elke HJ; Danhof, Meindert · Expert Opinion on Drug Metabolism & Toxicology · 2011
Introduction to computational oral absorption simulationSugano, Kiyohiko · Expert Opinion on Drug Metabolism & Toxicology · 2009
Pharmacokinetic evaluation of pemetrexedSørensen, Jens Benn · Expert Opinion on Drug Metabolism & Toxicology · 2011
Antisense oligonucleotide pharmacokinetics and metabolismGeary, Richard S · Expert Opinion on Drug Metabolism & Toxicology · 2009
Pharmacokinetic evaluation of pramipexoleAntonini, Angelo; Calandrella, Daniela · Expert Opinion on Drug Metabolism & Toxicology · 2011
Novel methods to assess bioequivalenceKaralis, Vangelis; Symillides, Mira; Macheras, Panos · Expert Opinion on Drug Metabolism & Toxicology · 2011
Pharmacokinetic evaluation of losartanBurnier, Michel; Wuerzner, Grégoire · Expert Opinion on Drug Metabolism & Toxicology · 2011